LUXTURNA

Product NDC
71394-415
11-digit product format
713940415
Labeler code
71394
Product ID
71394-415_173eb100-b8ab-4255-bad7-466d01195c6d
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
voretigene neparvovec-rzyl
Dosage form
KIT
Labeler
Spark Therapeutics, Inc.
Application
BLA125610
Marketing category
BLA
Marketing start
2017-12-19
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 6 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2024-03-11 06:39 UTC · source 2024-03-08excluded productproduct1332a3947898…d4bfe170f9cd…
2024-03-11 06:39 UTC · source 2024-03-08excluded packagepackage71394-415-011332a3947898…d4bfe170f9cd…
2022-04-09 23:13 UTC · source 2022-04-08excluded productproduct86f5da6cb304…a595104c45d7…
2022-04-09 23:13 UTC · source 2022-04-08excluded packagepackage71394-415-0186f5da6cb304…a595104c45d7…
2022-04-04 05:40 UTC · source 2022-04-01excluded productproductbd6a592717d7…303034d00443…
2022-04-04 05:40 UTC · source 2022-04-01excluded packagepackage71394-415-01bd6a592717d7…303034d00443…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
LUXTURNA
Listing expiration
2027-12-31

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1995884Internal RxNorm lookup
1995886Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
08313a24-e7ce-457a-bb3f-161bc45517eeAvailable on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
726062af-1135-4707-a1d7-57256991bbf9Product name220250226
362d7abb-94e6-4c60-9a58-266894157713Product name120231023
6bd95106-a412-1dad-b9cc-4cb74bfb27ceProduct name220230315
f1e0dc7e-7d61-4625-b6d9-4894927679d7Product name220211025
e4870509-7e28-6f92-f0be-dd3dd889a9cfProduct name520200810
6e9d4a47-c464-b93e-aebc-ad7bffc9c4cdProduct name220190619
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
290f523a-f9db-9774-b5a9-e1f908ac1782Product name120150828
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
19c71a3d-ed9c-166b-a7e5-38c250c35631Product name120140508
5668b646-cd56-c3c7-bdea-3f6b1a8840dbProduct name120140508
684ea482-2e8b-14af-5664-b98f1e402036Product name120140508
810ab97e-f109-f41c-7c83-6a652a9cbf43Product name120140508
87711080-88eb-65c5-b2dd-bf99e700a372Product name120140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2ddProduct name120140508
b060cc1a-fe47-856b-0b77-4448b5963de8Product name120140508
c6b65c52-69c7-df49-550a-a50c137f6218Product name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3Product name120140508

FDA-Initiated Inactive NDC Indexing#

Effective, Related label table
EffectiveRelated label
2024-04-16These highlights do not include all the information needed to use LUXTURNA safely and effectively. See full prescribing information for LUXTURNA. LUXTURNA (voretigene neparvovec-rzyl) intraocular suspension for subretinal injection Initial U.S. Approval: 2017
2024-04-16These highlights do not include all the information needed to use LUXTURNA safely and effectively. See full prescribing information for LUXTURNA. LUXTURNA (voretigene neparvovec-rzyl) intraocular suspension for subretinal injection Initial U.S. Approval: 2017
2024-01-30These highlights do not include all the information needed to use LUXTURNA safely and effectively. See full prescribing information for LUXTURNA. LUXTURNA (voretigene neparvovec-rzyl) intraocular suspension for subretinal injection Initial U.S. Approval: 2017
2024-01-30These highlights do not include all the information needed to use LUXTURNA safely and effectively. See full prescribing information for LUXTURNA. LUXTURNA (voretigene neparvovec-rzyl) intraocular suspension for subretinal injection Initial U.S. Approval: 2017
2022-06-22These highlights do not include all the information needed to use LUXTURNA safely and effectively. See full prescribing information for LUXTURNA. LUXTURNA (voretigene neparvovec-rzyl) intraocular suspension for subretinal injection Initial U.S. Approval: 2017
2022-06-22These highlights do not include all the information needed to use LUXTURNA safely and effectively. See full prescribing information for LUXTURNA. LUXTURNA (voretigene neparvovec-rzyl) intraocular suspension for subretinal injection Initial U.S. Approval: 2017
2022-01-28These highlights do not include all the information needed to use LUXTURNA safely and effectively. See full prescribing information for LUXTURNA. LUXTURNA (voretigene neparvovec-rzyl) intraocular suspension for subretinal injection Initial U.S. Approval: 2017
2022-01-28These highlights do not include all the information needed to use LUXTURNA safely and effectively. See full prescribing information for LUXTURNA. LUXTURNA (voretigene neparvovec-rzyl) intraocular suspension for subretinal injection Initial U.S. Approval: 2017

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
71394-065-01LUXTURNA1 in 1 VIAL, PLASTICINJECTION, SUSPENSION10.05 mg13
71394-415-01LUXTURNA1 in 1 CARTONKIT113

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
71394-415-01ML - Milliliter71394-41556a63088-8fb0-414d-b061-7e3270cc26d912018-02-20

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
71394-415LUXTURNA (VORETIGENE NEPARVOVEC-RZYL) KIT [SPARK THERAPEUTICS, INC.]11Current NDC, Legacy NDC, 2 package rows20240418_08313a24-e7ce-457a-bb3f-161bc45517ee.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LUXTURNAVORETIGENE NEPARVOVEC-RZYLSpark Therapeutics, Inc.08313a24-e7ce-457a-bb3f-161bc45517ee2022-05-01Warnings, Adverse reactionsExact identifier
application number: BLA125610
ndc (product): 71394-415

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125610LuxturnaVoretigene Neparvovec351(a)Rx2026-09-01

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1995886Luxturna 5,000,000,000,000 VECTOR-GENOMES/ML in 0.5 ML InjectionPSN08313a24-e7ce-457a-bb3f-161bc45517ee13
1995884voretigene neparvovec-rzyl 5,000,000,000,000 VECTOR-GENOMES/ML in 0.5 ML InjectionPSN08313a24-e7ce-457a-bb3f-161bc45517ee13
19958860.5 ML voretigene neparvovec-rzyl 5000000000000 VECTOR-GENOMES/ML Injection [Luxturna]SBD08313a24-e7ce-457a-bb3f-161bc45517ee13
19958840.5 ML voretigene neparvovec-rzyl 5000000000000 VECTOR-GENOMES/ML InjectionSCD08313a24-e7ce-457a-bb3f-161bc45517ee13
1995886Luxturna 5,000,000,000,000 VECTOR-GENOMES/ML per 0.5 ML InjectionSY08313a24-e7ce-457a-bb3f-161bc45517ee13
1995884voretigene neparvovec-rzyl 5,000,000,000,000 VECTOR-GENOMES/ML per 0.5 ML InjectionSY08313a24-e7ce-457a-bb3f-161bc45517ee13

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
71394-065-01713940065011 in 1 VIAL, PLASTICHistorical
71394-415-01713940415011 KIT in 1 CARTON (71394-415-01) * 1 INJECTION, SUSPENSION in 1 VIAL, PLASTIC (71394-065-01) * 1 INJECTION, SOLUTION in 1 VIAL, PLASTIC (71394-716-01) 1 kit2017-12-190000-00-00NoNoCurrent